Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma News 6_23
Cymbalta approved for Fibromyalgia - The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli …
Pharma News 5_16
There's a ton of stuff going on this week, plus we're in pre-ASCO mode (so lots of oncology news - scroll down for those headlines). Here we go: What's a vaptan? Maybe something pretty exciting - A …